These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1478604)

  • 1. [Effect of diuretics on serum lipoproteins].
    Sönnichsen AC; Richter WO; Schwandt P
    Fortschr Med; 1992 Nov; 110(33):625-8. PubMed ID: 1478604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diuretics on the plasma lipid profile.
    Weidmann P; de Courten M; Ferrari P
    Eur Heart J; 1992 Dec; 13 Suppl G():61-7. PubMed ID: 1486908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP
    Drugs; 1986 Oct; 32(4):335-57. PubMed ID: 2877846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect?
    Glück Z; Baumgartner G; Weidmann P; Peheim E; Bachmann C; Mordasini R; Flammer J; Keusch G
    Clin Sci Mol Med Suppl; 1978 Dec; 4():325s-328s. PubMed ID: 282079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with diuretics on serum lipoproteins.
    Weidmann P; Gerber A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S260-8. PubMed ID: 6204152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; Ferrier C; Saxenhofer H; Uehlinger DE; Trost BN
    Drugs; 1988; 35 Suppl 6():118-34. PubMed ID: 3042351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W
    Z Kardiol; 1992 Jun; 81(6):295-302. PubMed ID: 1353932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of diuretics and adrenergic-blocking agents on plasma lipids.
    Rohlfing JJ; Brunzell JD
    West J Med; 1986 Aug; 145(2):210-8. PubMed ID: 2876554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report.
    van der Heijden M; Donders SH; Cleophas TJ; Niemeyer MG; van der Meulen J; Bernink PJ; de Planque BA; van der Wall EE
    J Clin Pharmacol; 1998 Jul; 38(7):630-5. PubMed ID: 9702848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein levels during long-term treatment of hypertension with indapamide.
    Meyer-Sabellek W; Gotzen R; Heitz J; Arntz HR; Schulte KL
    Hypertension; 1985; 7(6 Pt 2):II170-4. PubMed ID: 4077236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
    Weinberger MH
    Arch Intern Med; 1985 Jun; 145(6):1102-5. PubMed ID: 2860883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension?
    Ames RP
    Am Heart J; 1987 Oct; 114(4 Pt 2):998-1006. PubMed ID: 2889346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.